Puma biotech Inc Live Stock Price Today, Share Analysis and Chart

Name: Puma Biotechnology Inc: Is Infosys Ltd. worth buying?
Item: Puma Biotechnology Inc
Rating: 2.465805625
Author: Trendlyne DVM scores

Turnaround Potential

about

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

6.90 0.14 (2.07%)

167.44% Gain from 52W Low

347.4K

XNAS Volume

XNAS 02 Apr, 2026 5:30 PM (EDT)

Medium Financial Strength

38.9 / 100

Affordable Valuation

53.2 / 100

Technically Moderately Bullish

66.3 / 100

Turnaround Potential These stocks have average financials with good valuations and momentum, indicating turnaround potential View Similar Embed DVM

1Yr Price target downside is -28%

1 analysts

Puma biotech Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Puma biotech Inc Live Stock Price Today, Share Analysis and Chart

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

167.44% Gain from 52W Low

SWOT Analysis

Puma biotech Inc Live Price Chart